PRESS RELEASES Webcast H.C. Wainwright Global Investment Conference 05/24/22 7:00 AM EDT Keyword Search Year: 2022202120202019201820172016201520142013 09/02/21 Summary Toggle TRACON Pharmaceuticals to Present at the Wells Fargo Virtual Healthcare Conference Printer Friendly PDF Version 08/11/21 Summary Toggle TRACON Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update Printer Friendly PDF Version 08/09/21 Summary Toggle TRACON Pharmaceuticals Announces Results of Second Independent Data Monitoring Committee Review of Safety Data from ENVASARC Pivotal Trial Printer Friendly PDF Version 08/03/21 Summary Toggle TRACON Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference Printer Friendly PDF Version 07/28/21 Summary Toggle TRACON to Report Second Quarter 2021 Financial Results and Company Highlights on August 11, 2021 Printer Friendly PDF Version 07/21/21 Summary Toggle TRACON Pharmaceuticals Increases Previously Announced Bought Deal Offering of Common Stock to $15.0 Million Printer Friendly PDF Version 07/21/21 Summary Toggle TRACON Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock Printer Friendly PDF Version 07/20/21 Summary Toggle TRACON Pharmaceuticals Announces Appointment of Brenda Marczi, PharmD, as Senior Vice President, Regulatory Affairs, and Granting of Inducement Award Printer Friendly PDF Version 06/30/21 Summary Toggle TRACON Pharmaceuticals Announces Appointment of Ya Huang as Executive Director of Statistical Programming and Granting of Inducement Award Printer Friendly PDF Version 06/29/21 Summary Toggle TRACON Pharmaceuticals Announces Orphan Drug Designation for Envafolimab in Soft Tissue Sarcoma Printer Friendly PDF Version Pagination First page First Previous page Previous … Page 2 Current page 3 Page 4 Page 5 … Next page Next Last page Last